A clinical trial to study the efficacy of D5 chooranam in patients with newly detected type 2 diabetes mellitus.
Phase 3
- Conditions
- Health Condition 1: null- newly detected Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2013/12/004231
- Lead Sponsor
- Central Council for Research in Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
males or females with a diagnosis of type 2 diabetes mellitus. Diabetes defined as those patients with fasting glucose levels of 110 mg/dl to 200 mg/dl and post prandial blood glucose 160 mg/dl to 350 mg/dl or HbA1c 6.5% to 10%
Exclusion Criteria
Malignant and accelerated hypertensive
CVS disorder (CAD)
Pregnant woman or the women planning to be pregnant in next six months
Lactating mothers
Secondary Diabetes mellitus
Patient undergoing regular treatment for Diabetes or for any other severe illness
CNS disorder e.g. encephalopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method If during treatment or after treatment fasting Blood sugar become less than 110 mg/dl. and post prandial Blood sugar become less than 160 mg/dl and HbA1c become less than 6.5 % it will be treated as successful outcome of the treatmentTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method The secondary outcome is during treatment or after treatment the lipid profile with in the normal limitTimepoint: 90 days